It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...

According to the agreement, Sanyou Bio will upgrade the development process through automation, substantially reducing the R&D timeline for innovative drugs. Through this strategic cooperation, Sanyou ...

POTOMAC, MARYLAND / ACCESS Newswire / / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a ...

Key opportunities in the preclinical CRO market lie in outsourcing R&D to streamline drug discovery and cut costs, with significant growth in AI-driven drug discovery. North America dominates, with ...

Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire / November 4, 2025 / Ignite Biomedical, Inc.

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop i ...